BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cleary CM, James S, Maher BJ, Mulkey DK. Disordered breathing in a Pitt-Hopkins syndrome model involves Phox2b-expressing parafacial neurons and aberrant Nav1.8 expression. Nat Commun 2021;12:5962. [PMID: 34645823 DOI: 10.1038/s41467-021-26263-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Martinowich K, Das D, Sripathy SR, Mai Y, Kenney RF, Maher BJ. Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome. Mol Psychiatry 2022. [PMID: 36224259 DOI: 10.1038/s41380-022-01811-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Bohlen JF, Cleary CM, Das D, Sripathy SR, Sadowski NL, Shim G, Kenney RF, Buchler IP, Mulkey DK, Maher BJ. Clemastine fumarate enhances myelination and promotes functional recovery in a syndromic ASD mouse model of Pitt-Hopkins Syndrome.. [DOI: 10.1101/2022.05.03.490512] [Reference Citation Analysis]
3 Martinowich K, Das D, Sripathy SR, Maher BJ. Evaluation of Nav1.8 as a therapeutic target for Pitt Hopkins Syndrome.. [DOI: 10.1101/2022.04.15.488505] [Reference Citation Analysis]
4 Bone M, Goodspeed K. A Case Report of Topiramate for Severe Breath Holding Spells in a Teenage Boy with Pitt-Hopkins Syndrome. Child Neurology Open 2022;9:2329048X2210931. [DOI: 10.1177/2329048x221093172] [Reference Citation Analysis]
5 Goshua A. Mouse model reveals root of breathing issues in rare form of autism. Spectrum 2021. [DOI: 10.53053/luyl3482] [Reference Citation Analysis]